Latest Breaking News On - Centre for nephrology - Page 1 : comparemela.com

Pure Transplant Solutions and King s College London to Support Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

AUSTIN, Texas /Massachusetts Newswire – National News/ Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial. The trial aims to determine whether adoptive transfer of regulatory T cells (Tregs) into HLA sensitised patients can suppress memory T and B cell responses against specific HLA antigens in order to extend the longevity of donor organs.

United kingdomCity ofUnited statesAnthony dorlingResearch excellence frameworkEmergent technologies incKing college londonPure proteinPure transplant solutionsUniversity of oklahomaNational newsQs world university rankingsCentre for nephrologyMassachusetts newswireCollege londonTransplant inflammation

Pure Transplant Solutions and King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial

(AUSTIN, Texas) NEWS: Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a collaboration agreement with King’s College London, a leading university providing world-class teaching and cutting-edge research, to support the Phase IIa GAMECHANgER-1 clinical trial. The trial aims to determine whether adoptive transfer of regulatory T cells (Tregs) into HLA sensitised patients can suppress memory T and B cell responses against specific HLA antigens in order to extend the longevity of donor organs.

United kingdomUnited statesCity ofAnthony dorlingResearch excellence frameworkEmergent technologies incKing college londonPure proteinPure transplant solutionsUniversity of oklahomaQs world university rankingsCentre for nephrologyCollege londonTransplant inflammationHonorary consultant nephrologistRico buchli

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease
californianewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from californianewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofAnthony dorlingResearch excellence frameworkEmergent technologies incKing college londonPure proteinPure transplant solutionsUniversity of oklahomaQs world university rankingsCentre for nephrologyCollege londonTransplant inflammationHonorary consultant nephrologistRico buchli

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease

Pure Transplant Solutions Announces Collaboration with King s College London to Support NHS Funded GAMECHANgER-1 Clinical Trial for HLA Sensitized Patients with End Stage Renal Disease
floridanewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridanewswire.com Daily Mail and Mail on Sunday newspapers.